CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
about
CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
description
scientific article published on 08 July 2019
@en
name
CRAF mutations in lung cancer ...... type II RAF and MEK inhibition
@en
type
label
CRAF mutations in lung cancer ...... type II RAF and MEK inhibition
@en
prefLabel
CRAF mutations in lung cancer ...... type II RAF and MEK inhibition
@en
P2093
P50
P1433
P1476
CRAF mutations in lung cancer ...... type II RAF and MEK inhibition
@en
P2093
Alfiah Noor
Bram Boeckx
Diether Lambrechts
Erik Teugels
Hugo Vandenplas
Jacques De Grève
Sylvia De Brakeleer
P304
P356
10.1038/S41388-019-0866-7
P577
2019-07-08T00:00:00Z